Cargando…
A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826131/ https://www.ncbi.nlm.nih.gov/pubmed/36094760 http://dx.doi.org/10.1002/cpdd.1171 |
| _version_ | 1784866778816446464 |
|---|---|
| author | He, Jimmy Zhijian Wang, Hechuan Lim, KyoungSoo Ren, Song Rollins, Fred Vallaster, Markus Wong, Ryan Stebbings, Richard Standifer, Nathan Keefe, Robert Phipps, Alex Gibbs, Megan |
| author_facet | He, Jimmy Zhijian Wang, Hechuan Lim, KyoungSoo Ren, Song Rollins, Fred Vallaster, Markus Wong, Ryan Stebbings, Richard Standifer, Nathan Keefe, Robert Phipps, Alex Gibbs, Megan |
| author_sort | He, Jimmy Zhijian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9826131 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98261312023-01-09 A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies He, Jimmy Zhijian Wang, Hechuan Lim, KyoungSoo Ren, Song Rollins, Fred Vallaster, Markus Wong, Ryan Stebbings, Richard Standifer, Nathan Keefe, Robert Phipps, Alex Gibbs, Megan Clin Pharmacol Drug Dev Commentary John Wiley and Sons Inc. 2022-09-12 2022-10 /pmc/articles/PMC9826131/ /pubmed/36094760 http://dx.doi.org/10.1002/cpdd.1171 Text en © 2022 The Authors. Clinical Pharmacology in Drug Development published by Wiley Periodicals LLC on behalf of American College of Clinical Pharmacology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Commentary He, Jimmy Zhijian Wang, Hechuan Lim, KyoungSoo Ren, Song Rollins, Fred Vallaster, Markus Wong, Ryan Stebbings, Richard Standifer, Nathan Keefe, Robert Phipps, Alex Gibbs, Megan A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies |
| title | A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies |
| title_full | A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies |
| title_fullStr | A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies |
| title_full_unstemmed | A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies |
| title_short | A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies |
| title_sort | consideration of fixed dosing versus body size‐based dosing strategies for chimeric antigen receptor t‐cell therapies |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826131/ https://www.ncbi.nlm.nih.gov/pubmed/36094760 http://dx.doi.org/10.1002/cpdd.1171 |
| work_keys_str_mv | AT hejimmyzhijian aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT wanghechuan aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT limkyoungsoo aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT rensong aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT rollinsfred aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT vallastermarkus aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT wongryan aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT stebbingsrichard aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT standifernathan aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT keeferobert aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT phippsalex aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT gibbsmegan aconsiderationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT hejimmyzhijian considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT wanghechuan considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT limkyoungsoo considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT rensong considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT rollinsfred considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT vallastermarkus considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT wongryan considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT stebbingsrichard considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT standifernathan considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT keeferobert considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT phippsalex considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies AT gibbsmegan considerationoffixeddosingversusbodysizebaseddosingstrategiesforchimericantigenreceptortcelltherapies |